RAFAEL
TABARES SEISDEDOS
CATEDRÁTICO/A DE UNIVERSIDAD
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario Marqués de Valdecilla (34)
2022
-
MICEmi: A method to identify cognitive endophenotypes of mental illnesses
European Psychiatry, Vol. 65, Núm. 1
2020
-
Childhood trauma and substance use underlying psychosis: a systematic review
European Journal of Psychotraumatology, Vol. 11, Núm. 1
-
Grip Strength, Neurocognition, and Social Functioning in People WithType-2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia
Frontiers in Psychology, Vol. 11
2019
-
Visual memory dysfunction as a neurocognitive endophenotype in bipolar disorder patients and their unaffected relatives. Evidence from a 5-year follow-up Valencia study.
Journal of Affective Disorders, Vol. 257, pp. 31-37
2018
-
Duration of active psychosis and functional outcomes in first-episode non-affective psychosis
European Psychiatry, Vol. 52, pp. 29-37
2017
-
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment
Psychopharmacology, Vol. 234, Núm. 17, pp. 2563-2570
-
Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study
Journal of Affective Disorders, Vol. 215, pp. 156-162
-
Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)
European Archives of Psychiatry and Clinical Neuroscience, Vol. 267, Núm. 4, pp. 315-323
2016
-
Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients
European Archives of Psychiatry and Clinical Neuroscience, Vol. 266, Núm. 7, pp. 619-628
2015
-
Disability in bipolar i disorder: The 36-item World Health Organization Disability Assessment Schedule 2.0
Journal of Affective Disorders, Vol. 174, pp. 353-360
-
Suicidal behaviour in first-episode non-affective psychosis: Specific risk periods and stage-related factors
European Neuropsychopharmacology, Vol. 25, Núm. 12, pp. 2278-2288
2014
-
Alzheimer's disease and cancer: Current epidemiological evidence for a mutual protection
Neuroepidemiology
-
Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis
Schizophrenia Research, Vol. 159, Núm. 1, pp. 90-94
-
Course of weight gain and metabolic abnormalities in first treated episode of psychosis: The first year is a critical period for development of cardiovascular risk factors
International Journal of Neuropsychopharmacology, Vol. 17, Núm. 1, pp. 41-51
-
Inverse and direct cancer comorbidity in people with central nervous system disorders: A meta-analysis of cancer incidence in 577,013 participants of 50 observational studies
Psychotherapy and Psychosomatics, Vol. 83, Núm. 2, pp. 89-105
-
Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis
Psychological Medicine, Vol. 44, Núm. 1, pp. 37-50
2013
-
Course of cognitive deficits in first episode of non-affective psychosis: A 3-year follow-up study
Schizophrenia Research, Vol. 150, Núm. 1, pp. 121-128
-
Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: A randomized comparison of haloperidol, olanzapine, and risperidone
Psychopharmacology, Vol. 227, Núm. 4, pp. 615-625
-
Prediction of acute clinical response following a first episode of non affective psychosis: Results of a cohort of 375 patients from the Spanish PAFIP study
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 44, pp. 162-167
-
Predictors of neurocognitive impairment at 3years after a first episode non-affective psychosis
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 43, pp. 23-28